{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:37:11Z","timestamp":1792445831080,"version":"4.5.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Leukemia cutis (LC) is an extramedullary acute myeloid leukemia (AML) infiltrate. No previous study has described the clinical characteristics and outcomes of Thai patients diagnosed with AML with LC.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>We conducted a 7-year retrospective case-control study on Thai AML patients at Siriraj Hospital from November 2013 to July 2020. Patients were divided into LC and non-LC groups. Initial clinical presentations and laboratory findings were examined to identify LC-associated factors. Overall survival (OS) and relapse-free survival (RFS) were assessed. Pathological tissues underwent re-evaluation to validate the LC diagnoses.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The study included 159 patients in a 2:1 ratio (106 non-LC and 53 LC). The LC group had a mean \u00b1 SD age of 54.3 \u00b1 15.5 years; females were predominant. Three-fifths of the LC patients had intermediate-risk cytogenetics; 20.4% had an adverse risk, and 10.2% had a favorable risk. Most were classified as AML-M4 and AML-M5. Leukemic nodules were the primary finding in 58.5% of the cases, mainly on the legs. In the multivariate analysis of predictive factors associated with LC, organomegalies, specifically hepatomegaly, and lymphadenopathy, remained significant factors associated with LC [OR 4.45 (95%CI 1.20, 16.50); p = 0.026 and OR 5.48 (95%CI 1.65, 18.20); p = 0.005], respectively. The LC group demonstrated a significantly reduced OS (log-rank test p = 0.002) (median OS of 8.6 months vs. 32.4 months). RFS was considerably lower in the LC group (log-rank test p = 0.001) (median duration of 10.3 months vs. 24.4 months in the non-LC).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>AML patients who developed LC tended to experience notably poorer prognoses. Therefore, it is imperative to consider aggressive treatment options for such individuals. The presence of organomegalies in AML patients serves as a strong predictor of the possible occurrence of LC when accompanied by skin lesions.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0297805","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T18:29:38Z","timestamp":1708108178000},"page":"e0297805","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia"],"prefix":"10.1371","volume":"19","author":[{"given":"Chanakarn","family":"Kanitthamniyom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalothorn","family":"Wannaphut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-7813","authenticated-orcid":true,"given":"Penvadee","family":"Pattanaprichakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smith","family":"Kungwankiattichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1262-2005","authenticated-orcid":true,"given":"Weerapat","family":"Owattanapanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"15","key":"pone.0297805.ref001","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1182\/bloodadvances.2020001920","article-title":"American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults","volume":"4","author":"MA Sekeres","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"pone.0297805.ref002","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"H Dohner","year":"2017","journal-title":"Blood"},{"issue":"7","key":"pone.0297805.ref003","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1200\/JCO.1995.13.7.1800","article-title":"Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review","volume":"13","author":"JC Byrd","year":"1995","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0297805.ref004","first-page":"326","article-title":"Clinical characterization of leukemia cutis presentation","volume":"104","author":"W Haidari","year":"2019","journal-title":"Cutis"},{"issue":"3","key":"pone.0297805.ref005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2340\/00015555-1458","article-title":"Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia","volume":"93","author":"MY Hurley","year":"2013","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"pone.0297805.ref006","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1590\/abd1806-4841.20186327","article-title":"Clinical and pathological features of myeloid leukemia cutis","volume":"93","author":"L Li","year":"2018","journal-title":"An Bras Dermatol"},{"key":"pone.0297805.ref007","volume-title":"Leukemia Cutis","author":"M Parsi","year":"2023"},{"issue":"2","key":"pone.0297805.ref008","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PAI.0b013e3181bfbcdc","article-title":"Leukemia cutis: case report and review of literature","volume":"18","author":"MR Hussein","year":"2010","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"pone.0297805.ref009","first-page":"57","article-title":"Histologically proven leukemia cutis carries a poor prognosis in acute nonlymphocytic leukemia","volume":"39","author":"BS Shaikh","year":"1987","journal-title":"Cutis"},{"issue":"4","key":"pone.0297805.ref010","first-page":"266;71;72","article-title":"Leukemia cutis in acute myeloid leukemia signifies a poor prognosis","volume":"102","author":"JA Krooks","year":"2018","journal-title":"Cutis"},{"issue":"2","key":"pone.0297805.ref011","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1365-2230.2005.02022.x","article-title":"Spectrum of clinical presentation, treatment and prognosis in a series of eight patients with leukaemia cutis","volume":"31","author":"KM Watson","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"pone.0297805.ref012","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"H Agis","year":"2002","journal-title":"Ann Hematol"},{"issue":"7","key":"pone.0297805.ref013","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1001\/jamadermatol.2019.0052","article-title":"Association of Leukemia Cutis With Survival in Acute Myeloid Leukemia.","volume":"155","author":"CX Wang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"pone.0297805.ref014","doi-asserted-by":"crossref","first-page":"adv00647","DOI":"10.2340\/actadv.v102.1123","article-title":"Leukaemia Cutis: Clinical Features and Outcomes of 56 Patients.","volume":"102","author":"HJ Yook","year":"2022","journal-title":"Acta Derm Venereol."},{"issue":"1 Pt 1","key":"pone.0297805.ref015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jfma.2020.04.025","article-title":"Leukemia cutis in a medical center in southern Taiwan: A retrospective study of 42 patients","volume":"120","author":"YW Chang","year":"2021","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"pone.0297805.ref016","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.ad.2016.02.015","article-title":"Leukemia Cutis: A Report of 17 Cases and a Review of the Literature.","volume":"107","author":"L Martinez-Leborans","year":"2016","journal-title":"Actas Dermosifiliogr."},{"issue":"4","key":"pone.0297805.ref017","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3346\/jkms.2013.28.4.614","article-title":"Clinical characteristics of 75 patients with leukemia cutis","volume":"28","author":"YS Kang","year":"2013","journal-title":"J Korean Med Sci"},{"issue":"2","key":"pone.0297805.ref018","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1309\/AJCPFMNYCVPDEND0","article-title":"Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases","volume":"135","author":"C Benet","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"6 Pt 1","key":"pone.0297805.ref019","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0190-9622(99)70086-1","article-title":"Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria","volume":"40","author":"S Kaddu","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"pone.0297805.ref020","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/1097-0142(19890601)63:11<2192::AID-CNCR2820631122>3.0.CO;2-R","article-title":"Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986","volume":"63","author":"MR Baer","year":"1989","journal-title":"Cancer"},{"issue":"3","key":"pone.0297805.ref021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0560.1992.tb01658.x","article-title":"Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers.","volume":"19","author":"KV Ratnam","year":"1992","journal-title":"J Cutan Pathol."},{"key":"pone.0297805.ref022","first-page":"15","article-title":"Leukemia cutis: a clinico-pathologic study of 23 patients","volume":"38","author":"CD Jang KA","year":"2000","journal-title":"Korean J Dermatol"},{"issue":"3","key":"pone.0297805.ref023","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5114\/ada.2021.107923","article-title":"Leukaemia cutis for clinicians, a literature review.","volume":"38","author":"M Osmola","year":"2021","journal-title":"Postepy Dermatol Alergol"},{"issue":"3","key":"pone.0297805.ref024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2016.02.020","article-title":"Cutaneous manifestations in leukemia patients","volume":"43","author":"MR Grunwald","year":"2016","journal-title":"Semin Oncol"},{"issue":"3","key":"pone.0297805.ref025","first-page":"223","article-title":"Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis","volume":"13","author":"WP Su","year":"1994","journal-title":"Semin Dermatol"},{"issue":"2","key":"pone.0297805.ref026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00000372-198504000-00002","article-title":"Leukemia cutis. A histopathologic study of 42 cases","volume":"7","author":"SA Buechner","year":"1985","journal-title":"Am J Dermatopathol."},{"issue":"4","key":"pone.0297805.ref027","first-page":"ECR13","article-title":"Leukaemia cutis: clinical features and treatment strategies","volume":"84","author":"S VM Zweegman","year":"2002","journal-title":"Haematologica"},{"issue":"1","key":"pone.0297805.ref028","first-page":"27","article-title":"Leukemia cutis\u2014epidemiology, clinical presentation, and differential diagnoses.","volume":"10","author":"G Wagner","year":"2012","journal-title":"J Dtsch Dermatol Ges."},{"issue":"1","key":"pone.0297805.ref029","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1309\/AJCP6GR8BDEXPKHR","article-title":"An updated approach to the diagnosis of myeloid leukemia cutis","volume":"132","author":"DM Cronin","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"pone.0297805.ref030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","article-title":"Leukemia cutis.","volume":"129","author":"JH Cho-Vega","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"pone.0297805.ref031","first-page":"1118","volume-title":"Skin Pathology.","author":"D. Weedon","year":"2002","edition":"2"},{"issue":"8","key":"pone.0297805.ref032","doi-asserted-by":"crossref","first-page":"e6009","DOI":"10.1002\/ccr3.6009","article-title":"Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia","volume":"10","author":"F Dadrass","year":"2022","journal-title":"Clin Case Rep"},{"issue":"2","key":"pone.0297805.ref033","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.bmt.1700857","article-title":"Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis","volume":"20","author":"G Michel","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"pone.0297805.ref034","first-page":"53","article-title":"A Sign of Relapse. Clinical Dermatology Review.","volume":"6","author":"AS Chitapur UG","year":"2022","journal-title":"Clin Dermatol Rev"},{"issue":"4","key":"pone.0297805.ref035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00019606-200012000-00003","article-title":"Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis).","volume":"9","author":"F Sen","year":"2000","journal-title":"Diagn Mol Pathol"},{"issue":"1","key":"pone.0297805.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.1999.tb01782.x","article-title":"Specific skin manifestations in CD56 positive acute myeloid leukemia","volume":"26","author":"H Kuwabara","year":"1999","journal-title":"J Cutan Pathol"},{"issue":"5","key":"pone.0297805.ref037","first-page":"1235","article-title":"Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461","volume":"4","author":"JC Byrd","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"2","key":"pone.0297805.ref038","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1200\/JCO.1997.15.2.466","article-title":"Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.","volume":"15","author":"JC Byrd","year":"1997","journal-title":"J Clin Oncol."},{"issue":"5\u20136","key":"pone.0297805.ref039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/10428199609052439","article-title":"Tetrasomy 8 and t(1;11)(p32;q24) in acute myelo-monocytic leukemia with extensive leukemic cutaneous involvement.","volume":"20","author":"F Ferrara","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"pone.0297805.ref040","first-page":"439","article-title":"[Leukemia cutis: clinical features of 27 mexican patients and a review of the literature].","volume":"152","author":"AG Pena-Romero","year":"2016","journal-title":"Gac Med Mex."},{"issue":"1\u20132","key":"pone.0297805.ref041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/10428199509054767","article-title":"Isolated leukemia cutis and CNS involvement in combination with cytogenetic findings of trisomy 8\u2014two case reports","volume":"20","author":"B Kuschel","year":"1995","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"pone.0297805.ref042","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1365-2141.2004.05124.x","article-title":"FLT3 mutations in myeloid sarcoma","volume":"126","author":"MA Ansari-Lari","year":"2004","journal-title":"Br J Haematol"},{"issue":"2","key":"pone.0297805.ref043","first-page":"44","article-title":"Molecular and cellular aspects of extramedullary manifestations of acute myeloid leukemia","volume":"2","author":"KA Mohammadiasl J","year":"2016","journal-title":"J Cancer Metastasis Treat"},{"key":"pone.0297805.ref044","volume-title":"Clinical Hepatology: Principles and Practice of Hepatobiliary Diseases","author":"H RJ Dancygier","year":"2010"},{"issue":"2","key":"pone.0297805.ref045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1148\/radiol.2015142088","article-title":"Imaging for Staging and Response Assessment in Lymphoma.","volume":"276","author":"SA Johnson","year":"2015","journal-title":"Radiology"},{"issue":"28","key":"pone.0297805.ref046","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.","volume":"34","author":"PC Austin","year":"2015","journal-title":"Stat Med"},{"issue":"6","key":"pone.0297805.ref047","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/sim.6004","article-title":"A comparison of 12 algorithms for matching on the propensity score.","volume":"33","author":"PC Austin","year":"2014","journal-title":"Stat Med"},{"issue":"10","key":"pone.0297805.ref048","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/sim.9681","article-title":"A comparison of different methods to adjust survival curves for confounders.","volume":"42","author":"R Denz","year":"2023","journal-title":"Stat Med"},{"issue":"18","key":"pone.0297805.ref049","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1182\/blood-2010-08-302950","article-title":"AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance","volume":"117","author":"G Avvisati","year":"2011","journal-title":"Blood"},{"issue":"1","key":"pone.0297805.ref050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"JN Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"14","key":"pone.0297805.ref051","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2011-04-347229","article-title":"How I treat extramedullary acute myeloid leukemia","volume":"118","author":"RL Bakst","year":"2011","journal-title":"Blood"},{"issue":"1","key":"pone.0297805.ref052","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/asheducation-2016.1.348","article-title":"Mutations in AML: prognostic and therapeutic implications.","volume":"2016","author":"CD DiNardo","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"pone.0297805.ref053","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41467-021-23186-w","article-title":"RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis.","volume":"12","author":"RM Carr","year":"2021","journal-title":"Nat Commun."},{"issue":"1","key":"pone.0297805.ref054","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40364-020-00246-9","article-title":"Leukemia cutis with IDH1, DNMT3A and NRAS mutations conferring resistance to venetoclax plus 5-azacytidine in refractory AML.","volume":"8","author":"J Wang","year":"2020","journal-title":"Biomark Res."},{"issue":"8","key":"pone.0297805.ref055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ajh.26601","article-title":"Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia","volume":"97","author":"CD DiNardo","year":"2022","journal-title":"Am J Hematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297805","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T18:30:21Z","timestamp":1708108221000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0297805"}},"subtitle":[],"editor":[{"given":"Mehmet","family":"Baysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0297805","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}